about
Genome-editing Technologies for Gene and Cell TherapyDiversity of CRISPR-Cas immune systems and molecular machinesNeglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationExploiting CRISPR-Cas to manipulate Enterococcus faecalis populations.Applications of CRISPR technologies in research and beyond.High-throughput strategies for the discovery and engineering of enzymes for biocatalysis.Genetic engineering of a temperate phage-based delivery system for CRISPR/Cas9 antimicrobials against Staphylococcus aureus.CRISPR-Based Technologies and the Future of Food Science.Recent Advances in CRISPR-Cas9 Genome Editing Technology for Biological and Biomedical Investigations.Engineering and optimising deaminase fusions for genome editing.Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics.The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9.Antimicrobial Resistance: Its Surveillance, Impact, and Alternative Management Strategies in Dairy Animals.Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.Book Review: Quorum Sensing vs. Quorum Quenching: A Battle With No End in Sight.CRISPR-Cas antimicrobials: Challenges and future prospects.Microbial-derived products as potential new antimicrobials
P2860
Q26769662-87ED57CD-BCE6-4412-8881-A8BB7E51B4CDQ26778564-71F1BAB7-2BD9-425C-9DA7-DF98B117BE79Q28602660-542F7297-C3D0-41D2-A9BC-3E2620D5CE55Q33853796-8080814A-B2CD-41AE-8299-69020235075DQ34539796-3207CCF9-0EA5-4357-A806-BBBAE3FB2771Q36163361-78BF2A40-660F-43E3-B36C-F6DFC299885BQ37712935-47BDD06E-E7CA-4BE7-AB80-1C17ACC925F6Q38601313-2C163804-6F0D-46F3-BFCD-319727C54191Q38679054-91F11DD2-39D1-49DE-928D-7CFB0FF66C8CQ38800431-BF566C85-CBAA-4A25-AAFA-4063AA3C7900Q44875794-CF3CDB3F-C19D-4E58-92CB-3F6869840428Q48145454-4ACFA510-FF9F-41EB-9C23-14EC26D5614AQ48513977-6EBDD114-5343-44F7-A2AE-763C6EDC57B5Q50532218-C9645FAA-641C-44D7-9E69-8B7B9FB926B7Q55048807-0BB42B27-E661-450D-8F90-267D32445553Q55255774-30CB479A-BFD2-433F-B530-D9C90F5B027FQ57865591-D7DD6240-1DB6-4A83-937E-E44C764FED3C
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A CRISPR design for next-generation antimicrobials.
@ast
A CRISPR design for next-generation antimicrobials.
@en
A CRISPR design for next-generation antimicrobials.
@nl
type
label
A CRISPR design for next-generation antimicrobials.
@ast
A CRISPR design for next-generation antimicrobials.
@en
A CRISPR design for next-generation antimicrobials.
@nl
prefLabel
A CRISPR design for next-generation antimicrobials.
@ast
A CRISPR design for next-generation antimicrobials.
@en
A CRISPR design for next-generation antimicrobials.
@nl
P2860
P1433
P1476
A CRISPR design for next-generation antimicrobials.
@en
P2093
Ahmed A Gomaa
P2860
P2888
P356
10.1186/S13059-014-0516-X
P577
2014-11-08T00:00:00Z
P5875
P6179
1009375554